Does Lipoprotein(a) Play a Causal Role in ASCVD?
Medscape,
This transcript has been edited for clarity. Michelle L. O'Donoghue, MD, MPH: Hi.
This transcript has been edited for clarity. Michelle L. O'Donoghue, MD, MPH: Hi.
The findings imply that any interventions to reduce Lp(a) would need to happen before the disease is underway, researchers say.
] The Lipoprotein(a) Foundation announced today that it has expanded its global Scientific Advisory Board (SAB) to 27 members.
Advisory Board to Be Actively Involved in the First-Ever Prospective Patient Registry to Study Lp(a) in the U.S.